Checkpoint Trends
61.87
+1.21(+1.99%)
Market Cap₹33.20 Cr
PE Ratio386.69
IndustryHealthcare
Company Performance:
1D+1.99%
1M+39.60%
6M+184.85%
1Y+291.09%
5Y+1,210.81%
View Company Insightsright
More news about Checkpoint Trends
18Aug 25
Checkpoint Trends Limited Plans Fourfold Increase in Authorized Share Capital, Diversifies into Tobacco and Edible Oils
Checkpoint Trends Limited (BSE: 531099) has announced significant changes to its corporate structure and business focus. The company plans to increase its authorized share capital from Rs. 75.00 crores to Rs. 300.00 crores, expanding equity shares from 7.50 crore to 30.00 crore. The company also aims to diversify into tobacco-related trading and the edible oils business. These changes are subject to shareholder approval through a postal ballot process with e-voting scheduled from August 21 to September 20, 2025. The company views these moves as strategic steps to optimize resources, enhance efficiency, and create sustainable value for stakeholders.
Checkpoint Trends
61.87
+1.21
(+1.99%)
1 Year Returns:+291.09%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)